CRIS Relative Valuation
CRIS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CRIS is overvalued; if below, it's undervalued.
Historical Valuation
Curis Inc (CRIS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.99 is considered Undervalued compared with the five-year average of -4.74. The fair price of Curis Inc (CRIS) is between 1.24 to 1.98 according to relative valuation methord. Compared to the current price of 0.87 USD , Curis Inc is Undervalued By 29.91%.
Relative Value
Fair Zone
1.24-1.98
Current Price：0.87
29.91%
Undervalued
-0.74
PE
1Y
3Y
5Y
-0.90
EV/EBITDA
Curis Inc. (CRIS) has a current EV/EBITDA of -0.90. The 5-year average EV/EBITDA is -2.95. The thresholds are as follows: Strongly Undervalued below -13.56, Undervalued between -13.56 and -8.26, Fairly Valued between 2.35 and -8.26, Overvalued between 2.35 and 7.66, and Strongly Overvalued above 7.66. The current Forward EV/EBITDA of -0.90 falls within the Historic Trend Line -Fairly Valued range.
-1.10
EV/EBIT
Curis Inc. (CRIS) has a current EV/EBIT of -1.10. The 5-year average EV/EBIT is -4.34. The thresholds are as follows: Strongly Undervalued below -18.73, Undervalued between -18.73 and -11.53, Fairly Valued between 2.86 and -11.53, Overvalued between 2.86 and 10.05, and Strongly Overvalued above 10.05. The current Forward EV/EBIT of -1.10 falls within the Historic Trend Line -Fairly Valued range.
0.99
PS
Curis Inc. (CRIS) has a current PS of 0.99. The 5-year average PS is 19.91. The thresholds are as follows: Strongly Undervalued below -38.78, Undervalued between -38.78 and -9.44, Fairly Valued between 49.25 and -9.44, Overvalued between 49.25 and 78.59, and Strongly Overvalued above 78.59. The current Forward PS of 0.99 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Curis Inc. (CRIS) has a current P/OCF of 0.00. The 5-year average P/OCF is -4.67. The thresholds are as follows: Strongly Undervalued below -19.25, Undervalued between -19.25 and -11.96, Fairly Valued between 2.61 and -11.96, Overvalued between 2.61 and 9.90, and Strongly Overvalued above 9.90. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.42
P/FCF
Curis Inc. (CRIS) has a current P/FCF of -0.42. The 5-year average P/FCF is -5.93. The thresholds are as follows: Strongly Undervalued below -22.27, Undervalued between -22.27 and -14.10, Fairly Valued between 2.24 and -14.10, Overvalued between 2.24 and 10.40, and Strongly Overvalued above 10.40. The current Forward P/FCF of -0.42 falls within the Historic Trend Line -Fairly Valued range.
Curis Inc (CRIS) has a current Price-to-Book (P/B) ratio of -0.85. Compared to its 3-year average P/B ratio of -4.92 , the current P/B ratio is approximately -82.67% higher. Relative to its 5-year average P/B ratio of -1.21, the current P/B ratio is about -29.50% higher. Curis Inc (CRIS) has a Forward Free Cash Flow (FCF) yield of approximately -236.76%. Compared to its 3-year average FCF yield of -114.30%, the current FCF yield is approximately 107.14% lower. Relative to its 5-year average FCF yield of -78.85% , the current FCF yield is about 200.26% lower.
-0.85
P/B
Median3y
-4.92
Median5y
-1.21
-236.76
FCF Yield
Median3y
-114.30
Median5y
-78.85
Competitors Valuation Multiple
The average P/S ratio for CRIS's competitors is 1.73, providing a benchmark for relative valuation. Curis Inc Corp (CRIS) exhibits a P/S ratio of 0.99, which is -42.71% above the industry average. Given its robust revenue growth of 8.36%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CRIS decreased by 76.13% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 2.93M to 3.18M.
The secondary factor is the Margin Expansion, contributed -29.32%to the performance.
Overall, the performance of CRIS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is Curis Inc (CRIS) currently overvalued or undervalued?
Curis Inc (CRIS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.99 is considered Undervalued compared with the five-year average of -4.74. The fair price of Curis Inc (CRIS) is between 1.24 to 1.98 according to relative valuation methord. Compared to the current price of 0.87 USD , Curis Inc is Undervalued By 29.91% .
What is Curis Inc (CRIS) fair value?
CRIS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Curis Inc (CRIS) is between 1.24 to 1.98 according to relative valuation methord.
How does CRIS's valuation metrics compare to the industry average?
The average P/S ratio for CRIS's competitors is 1.73, providing a benchmark for relative valuation. Curis Inc Corp (CRIS) exhibits a P/S ratio of 0.99, which is -42.71% above the industry average. Given its robust revenue growth of 8.36%, this premium appears unsustainable.
What is the current P/B ratio for Curis Inc (CRIS) as of Jan 08 2026?
As of Jan 08 2026, Curis Inc (CRIS) has a P/B ratio of -0.85. This indicates that the market values CRIS at -0.85 times its book value.
What is the current FCF Yield for Curis Inc (CRIS) as of Jan 08 2026?
As of Jan 08 2026, Curis Inc (CRIS) has a FCF Yield of -236.76%. This means that for every dollar of Curis Inc’s market capitalization, the company generates -236.76 cents in free cash flow.
What is the current Forward P/E ratio for Curis Inc (CRIS) as of Jan 08 2026?
As of Jan 08 2026, Curis Inc (CRIS) has a Forward P/E ratio of -0.74. This means the market is willing to pay $-0.74 for every dollar of Curis Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Curis Inc (CRIS) as of Jan 08 2026?
As of Jan 08 2026, Curis Inc (CRIS) has a Forward P/S ratio of 0.99. This means the market is valuing CRIS at $0.99 for every dollar of expected revenue over the next 12 months.